Sensei Biotherapeutics Inc
SNSE
Market Cap$10.69M
Close$
$0.24
35% downside
Current Fair Value
35% downsideOvervalued by 35% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.69 Million |
|---|---|
| Enterprise Value | $4.54 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.2 |
| Beta | 0.21 |
| Outstanding Shares | 25,165,041 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -19.55 |
| Price to Sales | - |
| Price to Book Ratio | 0.38 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | -0.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.85 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sensei Biotherapeutics Inc
31 employeesSensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a p...